The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Immunomonitoring of Interventional Radiology Procedures in the Management of Hepatocellular Carcinoma
Official Title: Immunomonitoring of Interventional Radiology Procedures in the Management of Hepatocellular Carcinoma
Study ID: NCT04892810
Brief Summary: This cohort study compares immune response induced in two groups of small HCC patients treated by ablation (group1 RFA, group 2 MWA). Patients will benefit for tumoral and non tumoral biopsies prior to treatment and stepped peripheral blood samples juste before ablation and during the first month after.
Detailed Description:
Minimum Age: 40 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No